These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 10480909
1. Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans. Veugelers M, De Cat B, Ceulemans H, Bruystens AM, Coomans C, Dürr J, Vermeesch J, Marynen P, David G. J Biol Chem; 1999 Sep 17; 274(38):26968-77. PubMed ID: 10480909 [Abstract] [Full Text] [Related]
4. Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain. Saunders S, Paine-Saunders S, Lander AD. Dev Biol; 1997 Oct 01; 190(1):78-93. PubMed ID: 9331333 [Abstract] [Full Text] [Related]
7. Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family. Veugelers M, Vermeesch J, Reekmans G, Steinfeld R, Marynen P, David G. Genomics; 1997 Feb 15; 40(1):24-30. PubMed ID: 9070915 [Abstract] [Full Text] [Related]
8. K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. Watanabe K, Yamada H, Yamaguchi Y. J Cell Biol; 1995 Sep 15; 130(5):1207-18. PubMed ID: 7657705 [Abstract] [Full Text] [Related]
9. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Veugelers M, Cat BD, Muyldermans SY, Reekmans G, Delande N, Frints S, Legius E, Fryns JP, Schrander-Stumpel C, Weidle B, Magdalena N, David G. Hum Mol Genet; 2000 May 22; 9(9):1321-8. PubMed ID: 10814714 [Abstract] [Full Text] [Related]
10. Mapping of the rat glypican genes. Szpirer C, Szpirer J, Rivière M, Van Vooren P, Veugelers M, David G. Cytogenet Cell Genet; 2001 May 22; 93(1-2):83-6. PubMed ID: 11474185 [Abstract] [Full Text] [Related]
11. The glypican family of heparan sulfate proteoglycans: major cell-surface proteoglycans of the developing nervous system. Lander AD, Stipp CS, Ivins JK. Perspect Dev Neurobiol; 1996 May 22; 3(4):347-58. PubMed ID: 9117265 [Abstract] [Full Text] [Related]
12. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D. Nat Genet; 1996 Mar 22; 12(3):241-7. PubMed ID: 8589713 [Abstract] [Full Text] [Related]
13. Dally-like protein, a new Drosophila glypican with expression overlapping with wingless. Khare N, Baumgartner S. Mech Dev; 2000 Dec 22; 99(1-2):199-202. PubMed ID: 11091094 [Abstract] [Full Text] [Related]
14. Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system. Litwack ED, Stipp CS, Kumbasar A, Lander AD. J Neurosci; 1994 Jun 22; 14(6):3713-24. PubMed ID: 8207484 [Abstract] [Full Text] [Related]
15. Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation. Stipp CS, Litwack ED, Lander AD. J Cell Biol; 1994 Jan 22; 124(1-2):149-60. PubMed ID: 8294498 [Abstract] [Full Text] [Related]
16. Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Litwack ED, Ivins JK, Kumbasar A, Paine-Saunders S, Stipp CS, Lander AD. Dev Dyn; 1998 Jan 22; 211(1):72-87. PubMed ID: 9438425 [Abstract] [Full Text] [Related]
17. Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. Chen RL, Lander AD. J Biol Chem; 2001 Mar 09; 276(10):7507-17. PubMed ID: 11106655 [Abstract] [Full Text] [Related]
18. Differential heparan sulfate dependency of the Drosophila glypicans. Nakato E, Kamimura K, Knudsen C, Masutani S, Takemura M, Hayashi Y, Akiyama T, Nakato H. J Biol Chem; 2024 Jan 09; 300(1):105544. PubMed ID: 38072044 [Abstract] [Full Text] [Related]
19. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Matsuda K, Maruyama H, Guo F, Kleeff J, Itakura J, Matsumoto Y, Lander AD, Korc M. Cancer Res; 2001 Jul 15; 61(14):5562-9. PubMed ID: 11454708 [Abstract] [Full Text] [Related]
20. Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. Mast AE, Higuchi DA, Huang ZF, Warshawsky I, Schwartz AL, Broze GJ. Biochem J; 1997 Oct 15; 327 ( Pt 2)(Pt 2):577-83. PubMed ID: 9359432 [Abstract] [Full Text] [Related] Page: [Next] [New Search]